Skip to content
10-Q/A

Quarterly Report

Zander Therapeutics, Inc

0001607062-19-000292

← back to feed
Filed
Jun 28, 2019 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2019 · Sep 30, 2018 6.03M sh
Operating Cash Flow Q1 2019 · Sep 30, 2018 −$483.41K
Operating Cash Flow Q1 2019 · Sep 30, 2017 −$122.02K
Cash And Equivalents Q1 2019 · Sep 30, 2018 $301.91K
Cash And Equivalents Q1 2019 · Jun 30, 2018 $370.31K
Cash And Equivalents Q1 2019 · Sep 30, 2017 $53.83K
Cash And Equivalents Q1 2019 · Jun 30, 2017 $96.01K